← All stocks

Aclaris Therapeutics, Inc.

ACRS Net selling
CIK 0001557746 #2604 in the set updated 17 Sep 2026
Bought (120 mo)
$14.84M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$82.89M
$136.02K on a plan · $2.91M straight out of an exercise
Sold at will
$79.84M
89 of 111 sales
Net
−$68.05M
−$65.00M against sales at will

By person

29 insiders · 162 transactions
11.3×

Neal Walker holds 11.3 times base salary in stock. $6.99M of shares against $615.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Neal Walker last reported holding, valued at $4.53, the price Common Stock was last bought or sold at on the open market here, on 23 Apr 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
VIVO VENTURES VII, LLC entity
10% owner
$34.01M (10)
−$34.01M
2,858,569
$12.95M
−31.8%
Mehra Anand
Director
$5.50M (2)
$21.19M (1)
−$15.69M
4,177,456
$18.92M
+9.1%
Flynn James E
10% owner
$7.74M (14)
−$7.74M
4,123,266
$18.68M
−30.0%
Walker Neal
CEO
$167.50K (1)
$5.37M (18)
−$5.20M
1,543,886
$6.99M
+77.1%
Leonard Braden Michael
10% owner
$5.59M (21)
$1.36M (1)
+$4.23M
13,950,000
$63.19M
+48.5%
Ali-Jackson Kamil
Chief Legal Officer
$3.20M (22) scheduled
−$3.20M
160,214
$725.77K
+110.9%
Ruffo Frank
Chief Financial Officer
$43.51K (2)
$2.85M (9)
−$2.81M
201,883
$914.53K
+41.5%
Monahan Joseph
Chief Scientific Officer
$2.14M (13)
−$2.14M
265,855
$1.20M
+363.8%
Gordon David N.
Chief Medical Officer
$1.19M (5)
−$1.19M
147,447
$667.93K
SCHIFF ANDREW N
Director
$2.50M (1)
$3.65M (12)
−$1.15M
1,094,450
$4.96M
−5.7%
Tullman Stephen A.
Director
$739.79K (4)
+$739.79K
571,471
$2.59M
−6.3%
Manion Douglas J.
Pres and CEO
$99.81K (2)
+$99.81K
41,813
$189.41K
FMR LLC entity
See Remark 1
$82.26K (2)
−$82.26K
4,506,831
$20.42M
−13.9%
Balthaser Kevin
Chief Financial Officer
$74.97K (1)
$23.58K (2) scheduled
+$51.39K
187,453
$849.16K
+26,679%
Loerop James
Chief Business Officer
$99.96K (1)
$59.27K (1)
+$40.69K
192,260
$870.94K
+402.5%
Molineaux Christopher P.
Director
$38.00K (1)
−$38.00K
69,536
$315.00K
Powell Andrew Kenneth William
Director
$27.52K (3)
+$27.52K
33,523
$151.86K
Powala Christopher
Chief Reg & Develop Officer
272,163
$1.23M
+4.3%
Shanler Stuart
Chief Scientific Officer
272,047
$1.23M
+4.3%
Davis Hugh M.
President and COO
45,425
$205.78K
Humphries William D.
Director
45,105
$204.33K
GOWEN MAXINE
Director
33,334
$151.00K
MILANO VINCENT
Director
28,896
$130.90K
Reasons Bryan M.
Director
28,732
$130.16K
Hall Jesse Wayne
Chief Medical Officer
27,045
$122.51K
Kolbeck Roland Wilhelm
Chief Scientific Officer
23,990
$108.67K
Fair Brett
Chief Commercial Officer
10,582
$47.94K
+236.9%
Cawkwell Gail
Chief Medical Officer
9,593
$43.46K
Foresite Capital Management III, LLC entity
10% owner
8,276
$37.49K
−99.6%

No percentages here. This company's share count has moved by a factor of 2.1 over the window, from 71,430,942 to 147,198,893 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Mehra Anand
19 Nov 2024
Director
Buy
666,666
$2.25
$1.50M
Leonard Braden Michael
5 Aug 2024
10% owner
Buy indirect
206,025
$1.24
$256.36K
Leonard Braden Michael
2 Aug 2024
10% owner
Buy indirect
167,544
$1.29
$216.40K
Leonard Braden Michael
31 Jul 2024
10% owner
Buy indirect
100,000
$1.33
$132.64K
Leonard Braden Michael
30 Jul 2024
10% owner
Buy indirect
173,730
$1.30
$226.37K
Leonard Braden Michael
22 Jul 2024
10% owner
Buy indirect
17,716
$1.33
$23.56K
Leonard Braden Michael
19 Jul 2024
10% owner
Buy indirect
6,689
$1.30
$8.70K
Leonard Braden Michael
18 Jul 2024
10% owner
Buy indirect
130,317
$1.30
$169.56K
Leonard Braden Michael
5 Jul 2024
10% owner
Buy indirect
123,017
$1.15
$141.33K
Leonard Braden Michael
3 Jul 2024
10% owner
Buy indirect
143,288
$1.16
$166.07K
Leonard Braden Michael
2 Jul 2024
10% owner
Buy indirect
86,092
$1.14
$98.49K
Leonard Braden Michael
1 Jul 2024
10% owner
Buy indirect
107,434
$1.14
$122.18K
Leonard Braden Michael
28 Jun 2024
10% owner
Buy indirect
400,000
$1.13
$452.00K
Leonard Braden Michael
28 Jun 2024
10% owner
Buy indirect
801,000
$1.12
$896.56K
Leonard Braden Michael
27 Jun 2024
10% owner
Buy indirect
235,000
$1.15
$271.33K
Leonard Braden Michael
18 Jun 2024
10% owner
Buy indirect
50,000
$1.13
$56.51K
Leonard Braden Michael
17 Jun 2024
10% owner
Buy indirect
150,000
$1.13
$169.50K
Leonard Braden Michael
14 Jun 2024
10% owner
Buy indirect
345,000
$1.17
$402.20K
Leonard Braden Michael
13 Jun 2024
10% owner
Buy indirect
500,000
$1.15
$575.00K
Leonard Braden Michael
13 Jun 2024
10% owner
Buy indirect
28,621
$1.14
$32.76K
Leonard Braden Michael
12 Jun 2024
10% owner
Buy indirect
82,579
$1.14
$94.14K
Leonard Braden Michael
11 Jun 2024
10% owner
Buy indirect
1,000,000
$1.08
$1.08M
Powell Andrew Kenneth William
4 Mar 2024
Director
Buy
6,000
$1.25
$7.50K
Powell Andrew Kenneth William
1 Mar 2024
Director
Buy
8,500
$1.23
$10.46K
Balthaser Kevin
6 Sep 2023
Chief Financial Officer
Buy
9,490
$7.90
$74.97K
Loerop James
28 Aug 2023
Chief Business Officer
Buy
14,705
$6.80
$99.96K
Manion Douglas J.
17 Mar 2023
Pres and CEO
Buy
6,300
$7.86
$49.53K
Manion Douglas J.
9 Mar 2023
Pres and CEO
Buy
6,500
$7.74
$50.28K
Mehra Anand
22 Oct 2018
Director
Buy indirect
372,093
$10.75
$4.00M
Tullman Stephen A.
4 Oct 2018
Director
Buy
7,100
$14.00
$99.37K
Tullman Stephen A.
23 Aug 2018
Director
Buy
6,600
$15.00
$98.98K
Tullman Stephen A.
15 Aug 2018
Director
Buy
6,250
$15.97
$99.81K
Powell Andrew Kenneth William
16 May 2018
Director
Buy
500
$19.12
$9.56K
Ruffo Frank
7 May 2018
Chief Financial Officer
Buy
1,250
$18.22
$22.78K
Tullman Stephen A.
6 Apr 2018
Director
Buy
26,700
$16.54
$441.62K
Ruffo Frank
6 Apr 2018
Chief Financial Officer
Buy
1,250
$16.59
$20.74K
Walker Neal
5 Apr 2018
President and CEO
Buy
10,000
$16.75
$167.50K
SCHIFF ANDREW N
16 Aug 2017
Director
Buy indirect
108,601
$23.02
$2.50M

What was left out

Form 4 filings counted 343
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 12
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 19
Sales at will 89
Transactions with no price 0
Shares from compensation/vesting 7,189,262
Sales filed before the plan box existed 88
History held since 31 Aug 2016